News & Media

We invite you to follow our progress as we move forward in the completion and installation of our first high-efficiency,environmentally responsible urea manufacturing plants. Subscribe today to receive news, updates and investor alerts.

Press Releases

Plant Construction Updates

Sign Up for
Investor Alerts

press releases

BioNitrogen Corporation Closes On Funding Facility

  • Bion User
  • June. 28, 2012

BioNitrogen Corporation Announces Financing to Complete Basic Engineering With Granherne, a KBR Company

MIAMI, FL, Jun 28, 2012 (MARKETWIRE via COMTEX) — BioNitrogen Corporation (PINKSHEETS: BION) announces that it has closed on a convertible debenture facility of $400,000. The initial round of financing will allow Granherne, Inc., a KBR company, the global engineering firm, to complete the engineering report. The convertible debenture facility may be increased to $1 million.
Carlos A. Contreras, President & CEO of BioNitrogen, stated, “We are pleased about this pivotal point in BioNitrogen’s life. The closing of this funding facility will allow us to complete the basic engineering design and advance towards the process of building plants and producing urea.”

About BioNitrogen Corporation

BioNitrogen (PINKSHEETS: BION) is focused on building turnkey manufacturing facilities to produce urea, High nitrogen content urea is principally used in the agricultural industry as a crop fertilizer. Our innovative, patent-pending technologies transform residual agricultural waste and other biomass materials into high-quality bulk urea for sale to agricultural wholesalers and retailers. Additional information about BioNitrogen can be found at www.bionitrogen.com.

Safe Harbor Statement

The forward-looking statements contained in this document involve risks and uncertainties that may affect the Company’s operations, markets, products, services, prices and other factors as discussed in filings with the Securities and Exchange Commission. These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Company’s expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

CONTACT:
Adam Friedman
Principal
Adam Friedman Associates
Email Contact
917-675-6250

SOURCE: BioNitrogen Corporation

CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=898668DC5D67D838

Copyright 2012 Marketwire, Inc., All rights reserved.

Downloads

2014 Investor Fact Sheet

Investor Alerts

Please provide us with your email address to receive investor alerts and other news.

Investor Relations Contact

Molly Nuland

Pentant LLC
(203) 553-9825

BION@pentant.com

Select Language